ID   MCJB2
AC   CVCL_AV59
DR   Wikidata; Q54904515
RX   DOI=10.1158/1538-7445.AM2014-LB-95;
CC   Group: Triple negative breast cancer (TNBC) cell line.
CC   Doubling time: 55 hours (Direct_author_submission).
CC   Miscellaneous: Cell line information from personal communication of Marlow L.A.
ST   Source(s): Direct_author_submission
ST   Amelogenin: X
ST   CSF1PO: 9,12
ST   D13S317: 11,12
ST   D16S539: 11
ST   D18S51: 17
ST   D3S1358: 15,16
ST   D5S818: 11,13
ST   D7S820: 10
ST   D8S1179: 11,15
ST   FGA: 23
ST   TH01: 8,9
ST   TPOX: 8,11
ST   vWA: 15
DI   NCIt; C71732; Triple-negative breast carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 02-05-16; Last updated: 21-03-23; Version: 5
//
RX   DOI=10.1158/1538-7445.AM2014-LB-95;
RA   von Roemeling C.A., Marlow L.A., Miller J., Mathias A., Dawson L.,
RA   Harrison S., Hollister B.A., Radisky D.C., Copland J.A. III;
RT   "Estrogen receptor mRNA-directed therapy for triple-negative breast
RT   cancer.";
RL   Cancer Res. 74 Suppl. 1:LB95-LB95(2014).
//